How Big is the Sclerotherapy Market | Industry Trends & Forecast 2025

Code: MTA8847 Publication Date: Sep 2025

How Big is the Sclerotherapy Market?

According to 6Wresearch internal database and industry insights, the Global Sclerotherapy Market was valued at USD 0.4 Billion in 2024 and is expected to reach USD 0.58 Billion by 2031, growing at a compound annual growth rate of 5.12% during the forecast period (2025–2031).

Growing cases of varicose and spider veins, rising demand for minimally invasive treatments, and improvements in medical imaging and procedural technologies are all leading to the growing market. Additionally, increasing awareness about cosmetic and therapeutic vein treatments is further driving market adoption and expansion.

Key Growth Drivers of the Sclerotherapy Market

  • Varicose veins and venous disorders are becoming more common
  • Minimally invasive treatment methods are more popular
  • Growing knowledge of the therapeutic and aesthetic advantages
  • Developments in ultrasound-guided sclerotherapy methods
  • Growing healthcare costs and the construction of medical infrastructure

Sclerotherapy Market Trends

Sclerotherapy Market is witnessing major growth with trends such as increasing adoption of foam sclerotherapy due to higher efficacy and safety. The preference for outpatient and office-based procedures is rising, supported by advancements in ultrasound-guided interventions. Growing awareness about cosmetic treatment for spider veins is boosting demand. Cost-effective solutions and quicker recovery times are the main priorities of healthcare providers. Additionally, the market landscape is changing due to the growing use of safer treatment materials and sophisticated sclerosants. Furthermore, it is anticipated that continued research and development in targeted therapies and minimally invasive procedures will lead to additional innovation and market growth.

Emerging Developments in the Sclerotherapy Market

Emerging developments in the Sclerotherapy Market include next-generation sclerosants and improved catheter-based delivery systems. The goal of ongoing research is to increase treatment precision and lower the recurrence rates of venous disorders. Strategic collaborations between medical professionals and device manufacturers are expanding access to treatment. Investments in clinical research and technological advancements are also generating new opportunities for market expansion. Patients' increasing desire for minimally invasive, outpatient procedures that require less recovery time has led to an increase in the popularity of sclerosing treatments.

List of Leading Companies in the Sclerotherapy Market

Some of the leading companies include:

  • BTG plc (Boston Scientific Corporation)
  • Kreussler Pharma
  • AngioDynamics, Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Troikaa Pharmaceuticals Ltd.
  • Chiesi Farmaceutici S.p.A.
  • Guerbet Group
  • Takeda Pharmaceutical Company Limited
  • Pfizer Inc.
  • Novartis AG

Frequently Asked Questions About the Market Study (FAQs):

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All